The home of the Audio Journal of Oncology

Pexelizumab Reduces Mortality in High Risk Coronary Artery By-Pass Patients

AudioMedica News
AudioMedica News
Pexelizumab Reduces Mortality in High Risk Coronary Artery By-Pass Patients
Pexelizumab Reduces Mortality in High Risk Coronary Artery By-Pass Patients
/
Peter Smith
Peter Smith, Duke University Medical Center, Durham, NC
Late Breaking Clinical Trials, ACC Atlanta 2006, Sunday 12th March 2006
The drug pexelizumab, targeting inflammation, reduced the risk of death among patients about to have coronary artery by-pass grafting in the PRIMOCABG-II study. Peter Smith of Duke University told the ACC about his group’s findings.
[audio:https://www.audiomedica.com/podcasting/acc2006/peter_smith.mp3]

Further reading

Sign up for AudioMedica.com news

* = required field
Speciality